Bioxyne Ltd
ASX:BXN

Watchlist Manager
Bioxyne Ltd Logo
Bioxyne Ltd
ASX:BXN
Watchlist
Price: 0.026 AUD 13.04%
Market Cap: 53.3m AUD
Have any thoughts about
Bioxyne Ltd?
Write Note
BXN
/
Cash Flow Statement
/
Capital Expenditures

Bioxyne Ltd
Capital Expenditures

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Bioxyne Ltd
Capital Expenditures Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Capital Expenditures CAGR 3Y CAGR 5Y CAGR 10Y
Bioxyne Ltd
ASX:BXN
Capital Expenditures
-AU$492.7k
CAGR 3-Years
N/A
CAGR 5-Years
-51%
CAGR 10-Years
N/A
McPherson's Ltd
ASX:MCP
Capital Expenditures
-AU$2.7m
CAGR 3-Years
-2%
CAGR 5-Years
11%
CAGR 10-Years
20%
Star Combo Pharma Ltd
ASX:S66
Capital Expenditures
-AU$1.4m
CAGR 3-Years
42%
CAGR 5-Years
19%
CAGR 10-Years
N/A
Elixinol Wellness Ltd
ASX:EXL
Capital Expenditures
-AU$17k
CAGR 3-Years
63%
CAGR 5-Years
68%
CAGR 10-Years
N/A
B
Biome Australia Ltd
ASX:BIO
Capital Expenditures
-AU$21.6k
CAGR 3-Years
32%
CAGR 5-Years
47%
CAGR 10-Years
N/A
H
Hydration Pharmaceuticals Co Ltd
ASX:HPC
Capital Expenditures
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Bioxyne Ltd
Glance View

Market Cap
53.2m AUD
Industry
Consumer products

Bioxyne Ltd. engages in the research, development, market and distribution of health products. The company is headquartered in Sydney, New South Wales. The company went IPO on 2000-12-14. The firm is engaged in the development of, manufacture, marketing and distribution of consumer dietary supplements based on the probiotic strain of Lactobacillus Fermentum PCC. The firm operates through two segments wholesale sales and direct sales. The firm manufactures, market, supplies and distributes its probiotic strain for over the counter dietary supplement products for the food, health, pharmaceutical and agricultural businesses. The firm is focusing on developing a range of functional food and beauty products.

BXN Intrinsic Value
0.008 AUD
Overvaluation 70%
Intrinsic Value
Price
What is Intrinsic Value?

See Also

What is Bioxyne Ltd's Capital Expenditures?
Capital Expenditures
-492.7k AUD

Based on the financial report for Jun 30, 2024, Bioxyne Ltd's Capital Expenditures amounts to -492.7k AUD.

What is Bioxyne Ltd's Capital Expenditures growth rate?
Capital Expenditures CAGR 5Y
-51%

Over the last year, the Capital Expenditures growth was -740%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 211,300+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.